Ginna Laport
Technik-/Wissenschafts-/F&E-Leiter bei CARGO THERAPEUTICS, INC.
Vermögen: - $ am 31.05.2024
Profil
Ginna G.
Laport is currently the Chief Medical Officer at Cargo Therapeutics, Inc. She previously held positions as the National Chairman at Blood & Marrow Transplant Clinical Trials Network, Vice President-Clinical Development at Genentech, Inc., Vice President-Clinical Development at Corvus Pharmaceuticals, Inc., Assistant Professor at the University of Pennsylvania, and Professor at Stanford University School of Medicine.
She also served as the Chief Medical Officer at Tempest Therapeutics, Inc. Dr. Laport completed her undergraduate degree at Baylor University and her doctorate at The University of Texas at Austin.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
CARGO THERAPEUTICS, INC.
-.--% | 05.04.2024 | 0 ( -.--% ) | - $ | 31.05.2024 |
Aktive Positionen von Ginna Laport
Unternehmen | Position | Beginn |
---|---|---|
CARGO THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 17.10.2023 |
Ehemalige bekannte Positionen von Ginna Laport
Unternehmen | Position | Ende |
---|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Technik-/Wissenschafts-/F&E-Leiter | 01.10.2023 |
TEMPEST THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.10.2019 |
CORVUS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.09.2018 |
Stanford University School of Medicine | Corporate Officer/Principal | 01.10.2015 |
University of Pennsylvania | Corporate Officer/Principal | 01.01.2001 |
Ausbildung von Ginna Laport
The University of Texas at Austin | Doctorate Degree |
Baylor University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
CORVUS PHARMACEUTICALS, INC. | Health Technology |
TEMPEST THERAPEUTICS, INC. | Health Technology |
CARGO THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Blood & Marrow Transplant Clinical Trials Network | |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |